191 related articles for article (PubMed ID: 31382801)
1. Hydrazone, benzohydrazones and isoniazid-acylhydrazones as potential antituberculosis agents.
Sampiron EG; Costacurta GF; Baldin VP; Almeida AL; Ieque AL; Santos NC; Alves-Olher VG; Vandresen F; Gimenes AC; Siqueira VL; Caleffi-Ferracioli KR; Cardoso RF; Scodro RB
Future Microbiol; 2019 Jul; 14():981-994. PubMed ID: 31382801
[No Abstract] [Full Text] [Related]
2. Isoniazid-N-acylhydrazones as promising compounds for the anti-tuberculosis treatment.
Sampiron EG; Calsavara LL; Baldin VP; Montaholi DC; Leme ALD; Namba DY; Alves Olher VG; Caleffi-Ferraciolli KR; Cardoso RF; Siqueira VLD; Vandresen F; Scodro RBL
Tuberculosis (Edinb); 2023 Jul; 141():102363. PubMed ID: 37311289
[TBL] [Abstract][Full Text] [Related]
3. The Introduction of Hydrazone, Hydrazide, or Azepane Moieties to the Triterpenoid Core Enhances an Activity Against
Kazakova OB; Medvedeva NI; Smirnova IE; Lopatina TV; Veselovsky AV
Med Chem; 2021; 17(2):134-145. PubMed ID: 31939731
[TBL] [Abstract][Full Text] [Related]
4. Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis.
De Logu A; Onnis V; Saddi B; Congiu C; Schivo ML; Cocco MT
J Antimicrob Chemother; 2002 Feb; 49(2):275-82. PubMed ID: 11815568
[TBL] [Abstract][Full Text] [Related]
5.
Sampiron EG; Costacurta GF; Calsavara LL; Baldin VP; Silva GVD; Alves Olher VG; Ferraretto LH; Caleffi-Ferraciolli KR; Cardoso RF; Siqueira VLD; Vandresen F; Scodro RBL
Microb Drug Resist; 2021 Nov; 27(11):1564-1577. PubMed ID: 33913749
[TBL] [Abstract][Full Text] [Related]
6. Mechanochemical Synthesis and Biological Evaluation of Novel Isoniazid Derivatives with Potent Antitubercular Activity.
Oliveira PFM; Guidetti B; Chamayou A; André-Barrès C; Madacki J; Korduláková J; Mori G; Orena BS; Chiarelli LR; Pasca MR; Lherbet C; Carayon C; Massou S; Baron M; Baltas M
Molecules; 2017 Sep; 22(9):. PubMed ID: 28862683
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of 12 novel (-)-camphene-based 1,3,4-thiadiazoles against
F Costacurta G; Souza MR; Sampiron EG; Almeida AL; Baldin VP; Ieque AL; Santos NC; Amaral PH; Silva CC; Siqueira VL; Caleffi-Ferracioli KR; Cardoso RF; Vandresen F; Scodro RB
Future Microbiol; 2020 Jun; 15():723-738. PubMed ID: 32686961
[No Abstract] [Full Text] [Related]
8. Novel thiomorpholine tethered isatin hydrazones as potential inhibitors of resistant Mycobacterium tuberculosis.
Karunanidhi S; Chandrasekaran B; Karpoormath R; Patel HM; Kayamba F; Merugu SR; Kumar V; Dhawan S; Kushwaha B; Mahlalela MC
Bioorg Chem; 2021 Oct; 115():105133. PubMed ID: 34329993
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of novel isoniazid derivatives with potent antitubercular activity.
Martins F; Santos S; Ventura C; Elvas-Leitão R; Santos L; Vitorino S; Reis M; Miranda V; Correia HF; Aires-de-Sousa J; Kovalishyn V; Latino DA; Ramos J; Viveiros M
Eur J Med Chem; 2014 Jun; 81():119-38. PubMed ID: 24836065
[TBL] [Abstract][Full Text] [Related]
10. Development of antitubercular compounds based on a 4-quinolylhydrazone scaffold. Further structure-activity relationship studies.
Gemma S; Savini L; Altarelli M; Tripaldi P; Chiasserini L; Coccone SS; Kumar V; Camodeca C; Campiani G; Novellino E; Clarizio S; Delogu G; Butini S
Bioorg Med Chem; 2009 Aug; 17(16):6063-72. PubMed ID: 19620006
[TBL] [Abstract][Full Text] [Related]
11. Reversed isoniazids: Design, synthesis and evaluation against Mycobacterium tuberculosis.
Kumar M; Singh K; Ngwane AH; Hamzabegovic F; Abate G; Baker B; Wiid I; Hoft DF; Ruminski P; Chibale K
Bioorg Med Chem; 2018 Feb; 26(4):833-844. PubMed ID: 29373270
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterization and evaluation of antituberculosis activity of some hydrazones.
Koçyiğit KB; Rollas S
Farmaco; 2002 Jul; 57(7):595-9. PubMed ID: 12164221
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and anti-Mycobacterium tuberculosis activity of imide-β-carboline and carbomethoxy-β-carboline derivatives.
Lopes-Ortiz MA; Panice MR; Borges de Melo E; Ataide Martins JP; Baldin VP; Agostinho Pires CT; Caleffi-Ferracioli KR; Dias Siqueira VL; Bertin de Lima Scodro R; Sarragiotto MH; Cardoso RF
Eur J Med Chem; 2020 Feb; 187():111935. PubMed ID: 31816556
[TBL] [Abstract][Full Text] [Related]
14. New series of isoniazid hydrazones linked with electron-withdrawing substituents.
Vavříková E; Polanc S; Kočevar M; Košmrlj J; Horváti K; Bosze S; Stolaříková J; Imramovský A; Vinšová J
Eur J Med Chem; 2011 Dec; 46(12):5902-9. PubMed ID: 22018878
[TBL] [Abstract][Full Text] [Related]
15. Analytical and clinical performance characteristics of the Abbott RealTime MTB RIF/INH Resistance, an assay for the detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis in pulmonary specimens.
Kostera J; Leckie G; Tang N; Lampinen J; Szostak M; Abravaya K; Wang H
Tuberculosis (Edinb); 2016 Dec; 101():137-143. PubMed ID: 27865383
[TBL] [Abstract][Full Text] [Related]
16. New lipophilic isoniazid derivatives and their 1,3,4-oxadiazole analogues: Synthesis, antimycobacterial activity and investigation of their mechanism of action.
Vosátka R; Krátký M; Švarcová M; Janoušek J; Stolaříková J; Madacki J; Huszár S; Mikušová K; Korduláková J; Trejtnar F; Vinšová J
Eur J Med Chem; 2018 May; 151():824-835. PubMed ID: 29679902
[TBL] [Abstract][Full Text] [Related]
17. Combinatory activity of linezolid and levofloxacin with antituberculosis drugs in Mycobacterium tuberculosis.
Santos NCS; Scodro RBL; de Almeida AL; Baldin VP; Nakamura de Vasconcelos SS; Siqueira VLD; Caleffi-Ferracioli KR; Campanerut-Sá PAZ; Cardoso RF
Tuberculosis (Edinb); 2018 Jul; 111():41-44. PubMed ID: 30029913
[TBL] [Abstract][Full Text] [Related]
18. New one-pot synthesis of anti-tuberculosis compounds inspired on isoniazid.
Ghiano DG; Recio-Balsells A; Bortolotti A; Defelipe LA; Turjanski A; Morbidoni HR; Labadie GR
Eur J Med Chem; 2020 Dec; 208():112699. PubMed ID: 32927391
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, Spectroscopic, In-vitro and Computational Analysis of Hydrazones as Potential Antituberculosis Agents: (Part-I).
Thorat BR; Rani D; Yamgar RS; Mali SN
Comb Chem High Throughput Screen; 2020; 23(5):392-401. PubMed ID: 32209038
[TBL] [Abstract][Full Text] [Related]
20. Transferrin conjugates of antitubercular drug isoniazid: Synthesis and in vitro efficacy.
Sutar YB; Mali JK; Telvekar VN; Rajmani RS; Singh A
Eur J Med Chem; 2019 Dec; 183():111713. PubMed ID: 31557610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
